Advaita Bio Launches iSCanGuide Platform
Analysis based on 6 articles · First reported May 07, 2026 · Last updated May 07, 2026
The launch of iSCanGuide by Advaita Bio is expected to positively impact the biotechnology and software markets by providing a more efficient tool for complex genomic data analysis. This innovation could lead to faster research and development in related fields, potentially benefiting companies involved in drug discovery and personalized medicine.
Advaita Bio announced the launch of iSCanGuide, a new cloud-based platform designed to streamline single-cell and spatial transcriptomics analysis. This GPU-accelerated platform aims to transform weeks of manual data processing into minutes, integrating with Advaita Bio's existing iPathwayGuide platform. Mike Mattacola, CEO, and Dr. Sorin Drăghici, Founder and Chief Scientific Officer, emphasized the platform's ability to unify fragmented workflows and provide deeper biological insights for researchers.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard